Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: In this role, the Director, Medical Communications will lead the development and execution of a comprehensive medical communications strategy, ensuring alignment across internal and external stakeholders for select assets across pipeline, with focus on pancreatic cancer, NSCLC, colorectal cancer, and other solid tumors. This role will oversee scientific communications platforms, publication strategies and operations and contribute to medical content supporting the organization’s medical and scientific engagement efforts. In this role you will be responsible for:
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree
Number of Employees
501-1,000 employees